Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006170 · ClinicalTrials.gov registry record · Phase 4
Bupropion and Weight Control for Smoking Cessation - 1
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 349
- Enrollment target
NCT00006170: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT00006170 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 349 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006170, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 349 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.
Primary Outcome
Women were interviewed using the time-line follow-back method and expired-air carbon monoxide (CO) was collected using a Vitalograph BreathCO monitor. Salivary samples were collected immediately after each assessment visit (1, 3, 6, and 12 mo). A CO reading of 8ppm or less and cotinine level of \>15 micrograms/L were used to confirm non-smoking.
Interventions
- DRUG Placebo
- DRUG Bupropion
- BEHAVIORAL smoking cessation intervention
- BEHAVIORAL weight concerns intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2000-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
What the finished NCT00006170 record still lists
NCT00006170 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00006170 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006170 about?
NCT00006170 is a clinical study titled "Bupropion and Weight Control for Smoking Cessation - 1". The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.
What is the current status of trial NCT00006170?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 349 participants. The study started on 2000-09. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00006170?
The interventions under investigation include: Placebo (DRUG), Bupropion (DRUG), smoking cessation intervention (BEHAVIORAL), weight concerns intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00006170?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00006170's enrollment target sits among peer trials
349 240th of 2000 higher than 1,761 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia